Yann Herault

Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice

Y. Hérault, F. de Chaumont, J. Olivo-Marin, 2011, Journal of psychopharmacology.